TERRACCIANO, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 2.364
EU - Europa 923
AS - Asia 531
SA - Sud America 97
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.922
Nazione #
US - Stati Uniti d'America 2.349
IT - Italia 307
SG - Singapore 203
CN - Cina 202
RU - Federazione Russa 185
UA - Ucraina 140
DE - Germania 100
BR - Brasile 91
IE - Irlanda 61
TR - Turchia 54
SE - Svezia 44
FI - Finlandia 27
KR - Corea 25
GB - Regno Unito 13
HK - Hong Kong 13
NL - Olanda 13
CZ - Repubblica Ceca 12
VN - Vietnam 12
CA - Canada 10
IN - India 7
ES - Italia 6
AT - Austria 5
AZ - Azerbaigian 4
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
EU - Europa 2
FR - Francia 2
GT - Guatemala 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.922
Città #
Ann Arbor 579
Chandler 306
Woodbridge 236
Jacksonville 173
Wilmington 170
Princeton 166
Houston 150
Ashburn 93
Salerno 93
Singapore 78
Dublin 60
Izmir 53
Nanjing 45
Andover 35
Boardman 30
Dearborn 29
Beijing 28
Pellezzano 28
Moscow 24
Fisciano 18
Redwood City 17
Guangzhou 16
Fairfield 15
Naples 13
Dong Ket 12
Jiaxing 12
Changsha 11
Hebei 11
Hong Kong 11
Brno 10
Nanchang 9
Nuremberg 9
Düsseldorf 8
Mestre 8
Seattle 8
Shenyang 8
Washington 8
Norwalk 7
Pune 7
Ottawa 6
Caianello 5
Dallas 5
Falls Church 5
Jinan 5
Nürnberg 5
São Paulo 5
Amsterdam 4
Arzano 4
Council Bluffs 4
Los Angeles 4
Montreal 4
Nocera Superiore 4
Pignola 4
Pomigliano d'Arco 4
Pozzuoli 4
San Diego 4
Tianjin 4
Yubileyny 4
Baku 3
Belo Horizonte 3
Campinas 3
Chengdu 3
Chicago 3
Cormano 3
Curitiba 3
Edinburgh 3
Granada 3
Guarulhos 3
Messina 3
New York 3
Taranto 3
The Dalles 3
Vienna 3
Acerra 2
Assago 2
Aversa 2
Bari 2
Bonea 2
Centro 2
Charlotte 2
Donostia / San Sebastian 2
Dormagen 2
Dundee 2
Florianópolis 2
Groningen 2
Guatemala City 2
Haikou 2
Itajaí 2
Johannesburg 2
Lecco 2
Lodz 2
Mercogliano 2
Milan 2
Morciano di Leuca 2
Munich 2
Ningbo 2
Nola 2
Orvieto 2
Phoenix 2
Recife 2
Totale 2.777
Nome #
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 158
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 139
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 127
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 118
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 115
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 113
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 111
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 110
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 108
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 102
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 101
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 101
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 100
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 97
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 94
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 94
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 94
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 93
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 93
Hsp90 Activity Modulation by Plant Secondary Metabolites 90
Conformationally locked calixarene-based histone deacetylase inhibitors 88
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 84
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 81
Discovery of new potent molecular entities able to inhibit mPGES-1 81
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 78
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 77
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 76
Structural basis for the design and synthesis of selective HDAC inhibitors 75
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 74
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 74
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 73
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 72
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 71
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 70
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 66
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 64
Discovery of noscapine derivatives as potential β-tubulin inhibitors 56
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 55
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 52
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 51
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 50
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 48
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 41
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 39
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 38
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 33
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 31
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 30
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 26
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 24
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 22
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 21
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 21
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 13
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 13
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 10
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 7
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 7
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 6
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 5
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 5
Totale 4.066
Categoria #
all - tutte 16.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 0 0 0 0 73 12
2020/2021293 4 26 29 2 39 21 40 4 59 7 36 26
2021/2022315 4 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025669 30 7 6 43 28 80 230 65 129 47 4 0
Totale 4.066